< Back to latest news & events

Event

German Biotechnology days 2021

August 2021

Event date: 20th September 2021

HGF’s Partner Dr Markus Zoller is attending and speaking at the German Biotechnology days on 20th September 2021.

German Biotechnology days is the go to event in the industry and is considered the German class reunion for biotechnology. It attracts entrepreneurs, scientists and partners from politics, funding institutions and administration. Speakers will discuss diverse fields of application and the potential of biotechnology, from health research to bioeconomy, from medicine to industrial production to plant breeding.

HGF’s Partner Dr Markus Zoller and Dr Thomas Tiller (MorphoSys AG) will be holding a luncheon session on 20th September, where they will cover ‘IP Portfolio Management – Aligning the Patent Portfolio with Business Goals’:

Intellectual property (IP) rights are completely worthless if they are not aligned with a company’s commercially relevant goals. Many companies are aware of the importance of IP rights. Thus, IP is now used not only to protect against imitation, but also as an attractive means to increase the value of a company. It is important here that the IP portfolio is aligned with the company’s orientation. What should I pay attention to in my IP strategy? How can I best adapt this strategy?

 

 

Latest updates

Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article